MicroRNAs: a new insight into cancer genome

Lin Zhang1, George Coukos

  • 1Center for Research on Reproduction and Women's Health, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. linzhang@mail.med.upenn.edu

Insights

Cancer genome research has overlooked noncoding sequences, particularly microRNAs (miRNAs). Understanding miRNA alterations in cancer is crucial for developing new diagnostic and therapeutic strategies.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • Cancer genome studies predominantly focus on protein-coding genes.
  • Functional noncoding sequences, crucial for gene regulation, are understudied in cancer.
  • MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression.

Purpose of the Study:

  • To highlight the importance of noncoding sequences, specifically miRNAs, in cancer genome research.
  • To emphasize the need for understanding miRNA alterations and their oncogenic properties.
  • To underscore the potential of miRNAs in cancer diagnosis and treatment.

Main Methods:

  • Review of existing literature on cancer genomics and miRNA research.
  • Analysis of miRNA-mediated gene regulation mechanisms.
  • Exploration of the role of altered miRNAs in tumorigenesis.

Main Results:

  • Significant knowledge gaps exist regarding noncoding sequence alterations in cancer genomes.
  • MicroRNAs regulate gene expression through translational inhibition or mRNA degradation.
  • Evidence suggests miRNAs play critical roles in tumor development.

Conclusions:

  • Further investigation into cancer genome alterations, including noncoding regions, is essential.
  • Understanding miRNA functions and alterations can significantly impact cancer diagnosis and therapy.
  • MicroRNAs represent a promising area for future cancer research and clinical applications.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...